Molecules of Man AB is a recent biotech start-up company, spun off from discoveries made at Karolinska Institutet, Stockholm, Sweden. It is privately held and was founded in 2005 by Drs. Tobias Allander, Mats A A Persson, and Mr. Staffan Söderström; it is registered in Stockholm, Sweden (CIN 556688-4978).
The company is focusing its efforts to develop human monoclonal antibodies for treatment
or protection against hepatitis C, a liver disease caused by the hepatitis C virus (HCV) and
estimated to affect 170 million people worldwide. Human antibodies against the HCV
surface proteins will be used; they have recently shown very potent and broad antiviral
effects against HCV of all known subfamilies. Patents covering the antibodies have been
granted and are fully owned by the company.
For more information, please contact:
Dr. Mats A A Persson
Molecules of Man AB
167 56 Bromma
Characteristics of some of the human antibodies have been published in:
Johansson DX, Voisset C, Tarr AW, Aung M, Ball JK, Dubuisson J, Persson MAA. Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proc Natl Acad Sci USA 2007;104:16269-16274.